Back to Newsroom
Back to Newsroom

SHAREHOLDER ALERT: CURLF ABMD VAL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Thursday, 26 September 2019 04:20 PM

The Law Offices of Vincent Wong

Topic:
5

NEW YORK, NY / ACCESSWIRE / September 26, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/curaleaf-holdings-inc-loss-submission-form?prid=3723&wire=1
Lead Plaintiff Deadline: October 4, 2019
Class Period: November 21, 2018 to July 22, 2019

Allegations against CURLF include that: (1) Curaleaf, on its website and social media pages, marketed its CBD products to be used as drugs and dietary supplements, contrary to law; (2) Curaleaf also sold unapproved animal drugs on its website; (3) such conduct would result in a warning letter from the U.S. Food and Drug Administration; and (4) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Abiomed, Inc. (NASDAQGS:ABMD)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/abiomed-inc-loss-submission-form?prid=3723&wire=1
Lead Plaintiff Deadline: October 7, 2019
Class Period: January 31, 2019 to July 31, 2019

Allegations against ABMD include that: (i) Abiomed's revenue growth was in decline; (ii) the Company did not have a sufficient plan in place to stem its declining revenue growth; (iii) the Company was unlikely to restore its revenue growth over the next several fiscal quarters; (iv) consequently, Abiomed was reasonably likely to revise its full-year 2020 guidance in a way that would fall short of the Company's prior projections and market expectations; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Valaris plc (NYSE:VAL)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/valaris-plc-loss-submission-form?prid=3723&wire=1
Lead Plaintiff Deadline: October 21, 2019
Class Period: April 11, 2019 to July 31, 2019

Allegations against VAL include that: (i) the Company was plagued by a weak ultra-deepwater segment, massive cash usage, and significant negative cash flow; (ii) the foregoing was reasonably likely to have a material negative impact on the Company's second quarter 2019 results; (iii) the merger leading to Valaris's establishment could not deliver on its touted benefits; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]

SOURCE: The Law Offices of Vincent Wong

Topic:
5
Back to newsroom
Back to Newsroom
Share by: